The Royal Pharmaceutical Society (RPS) and Pharmacist Support hosted a roundtable on the impact of pharmacy workforce wellbeing on patient safety on Wednesday
(17 May).
It also released its annual Workforce Wellbeing Survey which showed continued pressures on pharmacy teams.
The discussion explored the actions needed to support staff so they can continue providing safe and effective patient care and included representatives from the NHS,
professional bodies, employers, trade unions, education and regulators.
A report of the roundtable will be published in the summer.
Amandeep Doll, RPS Head of Professional Belonging, said: "We know that pharmacy teams go above and beyond for their patients, but are also under enormous pressure.
"Now more than ever, we need to strive to make the pharmacy profession more inclusive and ensure that everyone's wellbeing is supported.
"It is vital that we do all we can to encourage people into pharmacy and to support them so they can enhance their skills, develop their careers, and continue to
deliver high-quality patient care.
"This discussion was a welcome step and showed that making a difference for staff wellbeing requires a concerted effort from stakeholders across the whole of pharmacy.
The voter turnout for the Royal Pharmaceutical Society (RPS) England this year has dropped to 7.3 per cent.
Out of a total 18,333 eligible voter only 1,336 voter elected Danny Bartlett to the vacancy on the English Pharmacy Board.
This year, four nominations were received for one substantive place on the English Pharmacy Board.
One nomination was received for a single vacancy on the Welsh Pharmacy Board. Richard Evans has been elected unopposed to the vacancy on the Welsh Pharmacy Board.
There were no vacancies this year on the Scottish Pharmacy Board. Therefore, no election was required for the Welsh Pharmacy Board nor the Scottish Pharmacy Board.
Sarwat (Sorbi) Khattak has been elected for a period of one year to fill the casual vacancy.
Stone Pharmacy in Barnsley, South Yorkshire has been sold to existing operator, Livesey Healthcare, which owns another pharmacy in East Lancashire for an
undisclosed price.
Stone Pharmacy is a well-established, 100-hour community pharmacy that is run under full management with a locum Pharmacist, and dispenses an average of 22,000
items per month. The business adjoins Garland House surgery in the South Yorkshire village of Darfield, which is circa six miles east of Barnsley and circa 14 miles
north of Sheffield.
The pharmacy has been owned by experienced operators, Khuram Akhtar and Mohammed Ali, trading as MEDS2U Ltd, for the last seven years, and was recently brought to
market to allow the pair to pursue new ventures both in and out of community pharmacy.
Khuram Akhtar, former owner of Stone Pharmacy, commented: "The business at Stone Pharmacy has been a fantastic enterprise for many years for us, with limited
competition and a position central to the local community we have always enjoyed the support of the nearby population and are pleased that it is now in the hands
of experienced operators who can build on that foundation with the expansion of new services.
Fife-based trainee pharmacist and Honorary Secretary of the PDA LGBT+ Network, Soh Xi Ken has won the Scottish Trades Union Congress' (STUC) Equality Award.
One of Scotland's leading LGBT+ campaigners and Honorary Secretary of the PDA's LGBT+ Network has been recognised for his advocacy work for LGBT+ pharmacists
in Scotland.
Soh Xi Ken of the PDA received the Equality Award at the STUC Annual Congress in April 2023 in Dundee. The award praised Xi Ken's tireless advocacy for LGBT+ workers
within pharmacies in Scotland, highlighting his personal experience of homophobia in Scotland and his home country, Malaysia.
In May 2021, Xi Ken became a founding member of the PDA LGBT+ Network's committee and was elected as their first Honorary Secretary. The PDA LGBT+ Network is the
first of its kind in the pharmacy world and has made a significant difference to the profile of LGBT+ people in the profession.
Xi Ken and others within the PDA LGBT+ Network spotted that there was a lack of LGBT+-specific guidance given to pharmacy students and that their unique and specific
health needs were not being addressed as part of the pharmacy education that they received.
Despite being relatively new to the dispensing doctor market as a short-liner, Bestway Medhub is seeing exponential growth in the market in addition to
the 3,500 independent pharmacies that we service and deliver to.
We have however been servicing the dispensing doctor market for well over 40 years through our dispensing appliance contractor (DAC) Wardles.
Wardles service and supply more than 55% of all dispensing sites with dressings, bandages, appliances, ostomy, wound care and hosiery.
Graham Burford-Row
To meet the needs of dispensing practices and surgeries we carry a large range of more than 10,000 Generics, PI's and OTC products. We offer net pricing so the
practice can see straight away what price they are paying for their products - with no hidden fees.
We offer all our practices 24-hour online ordering via our Bestway Medhub ordering portal and our recently launched Wardles FP Portal. Additionally, we have the
backup of a telesales department with personal service from myself and a dedicated Internal Dispensing Dr Account Manager.
We offer daily, weekly or monthly calls to those customers wishing to hear our special offers. Our deliveries are done daily via our third party full-line logistics
partner for efficient deliveries, which no other short-line wholesaler offers.
Bestway Medhub understands that dispensing practices are not only in the business of offering superior care to their patients and community, but they also offer
numerous other services like clinics, nursing and referrals. By enabling practices to cost save, the funds could be used elsewhere instead.
A new residential building named after Dr Yusuf Hamied has opened at Christ's College, Cambridge, where the head of the Indian pharma giant, Cipla, was an
undergraduate and then PhD chemistry student between 1954 and 1960.
In more than 800 years that Cambridge University has been in existence, this is the first time an entire building has been named after an Indian.
The "grand opening of Yusuf Hamied Court" at Christ's was presided over by Lord Simon McDonald, the Master of the College, and attracted about 25 leading scientists,
mostly chemistry professors.
Professor Sir Venkatraman Ramakrishnan, a chemistry Nobel Prize winner and a former president of the Royal Society, was also present at the event earlier this month,
as well as Dr Anthony Freeling, the acting vice-chancellor of Cambridge University, and the chemist Dame Mary Archer, wife of the best-selling novelist Jeffrey
Archer.
Hamied and McDonald posed for photographs in front of the "entirely green" four-storey building, where the 64 rooms for postgraduates and fellows from around the
world will rely on heat exchangers, instead of gas.
Pfizer's plan to sell its Haleon stake is not a surprise, the consumer health company's finance chief Tobias Hestler told Reuters on Wednesday (3 May).
London-listed Haleon was carved out as an independent company in July and comprises consumer health assets once owned by GSK and Pfizer.
Pfizer, which has a 32% stake in the maker of Sensodyne toothpaste and Panadol painkillers, told the Financial Times on Tuesday that it intends to offload that stake
in a "slow and methodical" manner within months.
Hestler said Pfizer has long been clear about its intention to sell off the stake, suggesting that the reason the potential of the selloff has gained traction is
because the selling window opens around the time that Haleon's results are announced.
"This will happen every quarter from now until they're sold off…this is just what's expected," he said, adding: "If I get a courtesy call the evening before they
do it then that would be nice, but they don't even have to do that."
Shares of the world's biggest standalone consumer health business were down more than 3% in early trading.
The Pharmacists Defence Association (PDA) has expressed its keenness to work with the NHS nationally and at the ICB level to discuss how the pharmacist
workforce can most effectively be part of the multidisciplinary team, after the publication of Long-awaited NHS England workforce plan.
Welcoming its publication Alison Jones, PDA Director of Policy said: "It gives greater clarity around the future direction and strategy for professional development,
training, and opportunities for those currently working in the health service or considering their future career. There is a strong emphasis on further development
of the clinical role of pharmacists to support better patient care.
"However, this is a plan that will take years, indeed decades to come to fruition and its success will need to be underpinned by significant funding for its entire
life course.
Workplace pressures, reductions in support staff, and a lack of protected learning time are matters of immediate concern for many PDA members, issues which are
regularly highlighted through activities, such as the safer pharmacies survey.
Charac, an NHS-integrated one-stop platform for independent community pharmacies, has secured £1 million strategic investment from the Royal Mail Group,
enabling its time-saving platform to assist more local pharmacies and patients across the UK to easily manage their prescriptions and consultations online.
The company said this new money will enable it to leverage strong levels of trust that pharmacists enjoy within the communities they serve in and will ensure
pharmacies remain a cornerstone of vibrant high streets and an invaluable provider of frontline healthcare products and services, including vitally needed
consultations.
Charac says it is aiming to sign up over 1,000 UK pharmacies in the next 12 months by expanding its geographic footprint beyond current cities, including London,
Manchester and Birmingham, and targeting small multiple and independent pharmacies, accounting for almost 40 per cent of the UK's community pharmacy network.
The announcement also sees the addition of Stefan Kulik, a managing director at Royal Mail, to the Charac board. Stefan is responsible for leading Royal Mail's
expansion into the healthcare industry and brings a breadth of experience, having previously worked in healthcare with companies including Johnson & Johnson.
Pharmacy wholesaler PHOENIX UK is investing over £13 million to build a new state-of-the-art distribution hub in Wakefield.
The 260,000 sq. ft facility is expected to be operational next year and will service community pharmacies, hospitals and dispensing doctors across the North East
of England and Yorkshire.
In a statement on Tuesday (July 5), PHOENIX UK said the completed hub will feature 22 dock level loading bays and seven access doors to enable the productive arrival
and distribution of medical products.
It will also be highly energy efficient, including the use of Solar PV on its roof. The car park will also offer 46 electric vehicle charging bays.
Speaking at an official opening event held on 30 June to mark the expansion of the company's distribution capabilities, group managing director of PHOENIX Steve
Anderson said: "Over the last few years, we have seen an outstanding growth in customer demand for our core services outpacing the market: Wakefield is a prime
example of how we are committed to investing in the future by expanding our UK-wide operational capabilities to offer all our customers across the country the
best possible service they need, want and deserve.
England's chief pharmaceutical officer (CPhO) David Webb has promised his "wholehearted support" for the community pharmacy sector at the board meeting of the National Pharmacy Association (NPA) on 28 June in St Albans.
After hearing the CPhO at the meeting, NPA chair, Andrew Lane, later declared: "David is someone we can do business with."
Webb thus listed his priorities as head of profession: integration of independent prescribing as part of pharmacy practice by 2026; promotion of inclusive pharmacy
practice for all pharmacy professionals; assurance of post-registration practice; developing the role of pharmacy technicians; support for Integrated Care Systems
and Primary Care Network pharmacy teams (including community pharmacy); medicines optimisation; and strengthening of professional leadership for community pharmacy.
He also reported that NHS England had recently increased its team of regional pharmacy integration leads from seven to 14, creating seven new senior posts.
Webb told NPA board members: "I want sincerely to thank community pharmacy teams for everything they are doing and to say that you have my wholehearted support. I believe in the importance of community pharmacy and will listen and engage as I've already demonstrated.
The National Pharmacy Association (NPA) has commissioned Professor David Taylor of University College London to investigate the implications of all-time high
inflation rates on community pharmacies in the UK.
Professor Taylor's will assess rates of inflation affecting community pharmacy across the UK, using public data sources whilst examining inflated costs in the
context of the current five year contractual framework in England (2019-2024).
He would review the EY (Ernst & Young) report into pharmacy funding, to identify whether current inflationary pressures could change any of the findings and
consider the policy implications and impacts of inflationary pressures, including pharmacy's ability to prepare for a more clinically focused future and maintain
current core services.
NPA chief executive Mark Lyonette said: "Inflationary pressures are eating into the limited funds provided by the NHS for pharmacy services. We believe the real
level of inflation for pharmacy businesses could be higher than the CPI inflation rate, which itself is at a 40 year high. Staff and locum costs in the sector as
well as medicines costs have risen dramatically.
The Pharmaceutical Services Negotiating Committee (PSNC)'s 2022 Pharmacy Advice Audit revealed that more than 1.2 million consultations a week - or 65 million
a year - are now being carried out by community pharmacy teams in England.
This is an increase from 2021, when the audit results suggested that in total pharmacies were providing 58 million consultations per year.
PSNC has published the findings of the audit of over 4,000 community pharmacies carried out earlier this year. During the audit, 82,872 informal patient consultations
were recorded, with the average pharmacy completing 19 consultations per day.
This suggests that more than 1.2 million informal consultations are taking place in community pharmacies in England every week.
The audit helped to quantify the number of informal referrals being made to pharmacies by GPs and NHS 111, with 7,774 informal patient referrals into pharmacy
coming from these routes; grossed up to a national level that means 117,000 cases per week.
These are all referrals that could and should have been made by the NHS Community Pharmacist Consultation Service (CPCS).
From July 2022, Manage Your Services (MYS) portal will be the only route available for pharmacy contactors to submit all new prescription returns/referred
back items and disallowed items, reminded the Pharmaceutical Services Negotiating Committee (PSNC).
Contractors will be able to view and submit the required information for all these items only through the MYS portal.
The NHS Business Services Authority (NHSBSA) will send out a notification email from July (for the dispensing month of June) to the pharmacy NHSmail account if any
new referred back or disallowed items have been generated for the contractor to complete on their MYS account.
"Contractors can view any referred back items for completion by checking the 'Unpaid items' tab on MYS landing page," PSNC.
"It is important to note that prescription returns/referred back items via MYS are only held in the system for a period of 18 months from the date they are first
sent to the pharmacy for action; if contractors have not completed and returned any outstanding referred backs before this deadline has passed, the referred back
items will be deleted from system."
The Pharmacists' Defence Association (PDA) Union says it will be reaching out to LloydsPharmacy soon over a better deal on salary increase after the majority
of its members rejected a three per cent offer made by the company recently.
Paul Day, director, PDA Union told Pharmacy Business: "The PDA Union will communicate the response of employed pharmacists to the company and seek further discussion
to try and find an offer that will be acceptable to union members.
"Both management and union representatives have a vested interest in working to find such a solution and that is the outcome we hope to achieve."
After months of negotiation by the PDA Union, the company offered a three per cent increase in salaries from the 1.8 per cent in the earlier offer made by the
company.
"Through negotiation over last few months that was increased to 3.0 per cent, plus a long term incentive plan (LTIP). Though the LTIP potentially offers large
bonuses, it isn't guaranteed. Therefore what we put to members was the confirmed offer of three per cent increase in salaries," said Paul.
The Association of Independent Multiple Pharmacies (AIMP)'s members are not going to abandon the dosettes boxes, the association has announced. Instead, it
insisted that this service should be properly funded.
The association has emphasised on the importance of the service provided by pharmacists to elderly patients living independently.
Dr Leyla Hannbeck, chief executive of AIMP, said it was vital that patients for whom this service is suitable can continue accessing it and that it is properly
funded.
Blister pack trays or dosettes assist thousands of people across the UK in living independently and remaining in their own homes for longer.
"This is largely attributable to the care and professionalism shown by local pharmacies," said Hannbeck.
"Our members, as independent family-owned pharmacies, are not going to abandon this service for patients."
The recent announcement that Royal Mail will be partnering with distance selling pharmacy (DSP) giant pharmacy2U highlights how standards of regulatory
enforcement are being ignored to accommodate the DSP model.
The brunt of these double standards hinges around the levelling down of temperature enforcement standards by the Medicines and Healthcare products Regulatory
Agency (MHRA) which demands mapping must be audited from the point of dispensing to the patient.
The MHRA has a well recognised duty to ensure medicines reach patients in a safe condition. The current anomaly appears to turn a blind eye to this step in the
supply chain at the point the wholesaler releases goods to the pharmacy hub.
Equally the training on delivering medicines safely and effectively direct to patients should apply fully to all hubs including DSPs. Why is it that DSPs are being
treated differently to bricks and mortar pharmacies? It's essentially the same patients receiving the same medicines from the same wholesalers.
A further regulatory disparity exists around how parcels must be "tracked and signed for" to be reasonably certain medicines are delivered into the hand of the
intended recipient, as per existing regulations.
Clearly an untracked, unsigned package cannot be guaranteed to finish in the hands of the intended recipient.
There is a very real possibility that such omission could lead to community pharmacy closures which will, in turn, lead to unemployment and a reduction in the
care services. At a time when integrated care systems have just gone live, the removal of vital support services leading to further inequalities is the wrong
message for both providers and patients alike.
The Royal Pharmaceutical Society (RPS) has appointed Neville Carter as its new chief education and membership officer.
Neville joins RPS from the Royal Society of Medicine (RSM) where he is currently director of engagement, leading a team of over 60 and responsible for creating a
combined directorate accountable for education, membership, philanthropy, and business development.
He has, in particular, led on the development of a digital education strategy and launched professional development training programmes for members.
Prior to joining the RSM, Neville worked as director of product and sales at the British Medical Association with responsibility for membership growth, supporting
corporate transformation and developing and managing member benefits and relationships with third-party providers to support revenue growth. He also has senior
manager experience at the RAC and at British Airways.
Commenting on the appointment, Paul Bennett, RPS CEO, said: "I'm delighted that Neville will be joining our Executive team. He brings a wealth of relevant experience
and this, in combination with a strong existing education and membership team at RPS and a clear ambition to strengthen the relevant functions further, will enable
the organisation to deliver a dynamic offering for our members.
The European Union's population shrank for a second year running last year, the bloc's statistics office said on Monday, as the region reels from over two
million deaths from the coronavirus.
According to Eurostat, the population of the 27 countries that make up the bloc fell by close to 172,000 from the previous year and over 656,000 from January 2020.
"In 2020 and 2021 the positive net migration no longer compensated for the negative natural change in the EU and, as a consequence, the EU total population has been
decreasing," it said, pointing to impacts from the pandemic.
The number of deaths began outstripping births in the EU a decade ago, but immigration from outside the bloc helped offset the gap until the first year of the
pandemic.
The previous time the EU had registered a fall in population was in 2011 - the only other time since 1960 - but this rapidly picked up due to net migration.
The Pharmacists' Defence Association (PDA) has launched a brutal attack on some large pharmacy chains for full or part-day closures of some of their shops
throughout the UK.
It published an Open Letter on Tuesday (July 19) demanding urgent action "to protect patients by ensuring that essential community pharmacy services are provided
safely and consistently".
PDA chair Mark Koizol, who wrote the letter, went on to allege that many of those closure were "being orchestrated".
He wrote that the "pharmacist shortage" narrative cited as a reason for these closures was "very different" from "the reality experienced by our members", including
both employed and locum pharmacists.
"We have evidence to show that these closures are being announced up to four weeks in advance," Koizol claimed.
He gave examples of how a large company attempted to reduce the pre-agreed rate of locums and where this was not accepted, the shift was cancelled, resulting in the
pharmacy being closed for part or full day.